This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules used to ...

Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg have an estimated market size of US$ 28.2 ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

A driver and passenger were arrested early Thursday morning after an officer located boxes of Promethazine Hyrdochloride and ...

The company has received approval for its Abbreviated New Drug Application for Bupropion Hydrochloride extended-release ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...